The aim of the project is to use methods and processes of the Medical Informatics Initiative (MII) to contribute to the detection of health risks in patients with polypharmacy. Polypharmacy occurs especially in elderly patients with multimorbidity. Polypharmacy associated with an increased risk for medication errors and drug-drug or drug-disease interactions, which either reduce or intensify the desired effect of individual active substances or lead to undesired adverse drug effects (ADE). In the ...
Programme: MII - Medical Informatics Initiative
Public web page: https://www.medizininformatik-initiative.de/en/POLAR
Organisms: Homo sapiens
Autoren bzw. Ansprechpartner für diesen Datensatz sind: Universität Bonn: Anna Böhmer, Prof. Ulrich Jaehde Universitätsklinikum Bonn: Katharina Karsten Dafonte, Dr. med. Martin Coenen, Prof. Hartmann Bonn: Fr. Karsten Dafonte, Dr. med. Coenen, Prof. Hartmann
Submitter: Frank A. Meineke
Resource type: Experimental Assay Type
Technology type: Technology Type
Study: FHIR Testdata
Human Diseases: No human diseases
SOPs: No SOPs
Data files: FHIR Testdata UKB
Snapshots: No snapshots
Authors: V. Poeschel, G. Held, M. Ziepert, M. Witzens-Harig, H. Holte, L. Thurner, P. Borchmann, A. Viardot, M. Soekler, U. Keller, C. Schmidt, L. Truemper, R. Mahlberg, R. Marks, H. G. Hoeffkes, B. Metzner, J. Dierlamm, N. Frickhofen, M. Haenel, A. Neubauer, M. Kneba, F. Merli, A. Tucci, P. de Nully Brown, M. Federico, E. Lengfelder, A. di Rocco, R. Trappe, A. Rosenwald, C. Berdel, M. Maisenhoelder, O. Shpilberg, J. Amam, K. Christofyllakis, F. Hartmann, N. Murawski, S. Stilgenbauer, M. Nickelsen, G. Wulf, B. Glass, N. Schmitz, B. Altmann, M. Loeffler, M. Pfreundschuh
Date Published: 21st Dec 2019
Publication Type: Journal article
PubMed ID: 31868632
Citation: Lancet. 2019 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9.
The medical informatics initiative was created to close the gap between research and healthcare. All of Germany’s university hospitals have joined forces with research institutions, businesses, health insurers, and patient advocacy groups to create a framework that harnesses research findings to the direct benefit of patients. The German Federal Ministry of Education and Research (BMBF) is investing around 160 million euros in the programme through 2021. The digitisation of medicine is creating ...